Medpace Holdings earnings were $418.3M for the trailing 12 months ending Jun 30, 2025, with 25.4% growth year over year. The latest MEDP earnings report on Jun 30, 2025 announced Q2 2025 earnings of $90.3M, down 21.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MEDP reported annual earnings of $404.4M, with 43% growth.
MEDP past earnings growth
How has MEDP's earnings growth performed historically?
What were Medpace Holdings's earnings last quarter?
On MEDP's earnings call on Invalid Date, Medpace Holdings (NASDAQ: MEDP) reported Q2 2025 earnings per share (EPS) of $3.16, up 10.88% year over year. Total MEDP earnings for the quarter were $90.26 million. In the same quarter last year, Medpace Holdings's earnings per share (EPS) was $2.85.
As of the last Medpace Holdings earnings report, Medpace Holdings is currently profitable. Medpace Holdings's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $418.30 million, a 23.11% increase year over year.
What was MEDP's earnings growth in the past year?
As of Medpace Holdings's earnings date in Invalid Date, Medpace Holdings's earnings has grown 25.41% year over year. This is 14.4 percentage points higher than the US Diagnostics & Research industry earnings growth rate of 11.01%. MEDP earnings in the past year totalled $418.30 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.